Rx Minute: Statins Value to Society & Risk Factors Linked to Alzheimer's

A recent article published in Health Affairs highlights the remarkable impact of cholesterol-lowering drugs known as statins on the treatment of cardiovascular disease in the U.S.

Research Key to Medical “Miracles”

04.11.13 | By

The second #PhRMA13 panel begins at 1:45 pm EDT and will address medical breakthroughs and what needs to change to speed personalized medicine to patients. In a guest post, John Crosby, Executive Director at the American Osteopathic Association, addresses what he believes is necessary to bring science from the lab to the patient.

Pivotal Time for U.S. Biopharmaceutical Industry

04.11.13 | By

PhRMA Chairman and Lilly President and CEO John Lechleiter is kicking off #PhRMA13 now. In a guest post he discusses the future of the industry. To learn more watch live now!

For decades, San Diego has been at the center of the biotech revolution. The advances pioneered by scientists in the San Diego area have had a dramatic impact on human well-being and longevity. 

New PhRMA.org Launches Just in Time For #PhRMA13

04.11.13 | By

As we gear up for discussion today around research, progress and hope at our 2013 Annual Meeting in San Diego, we are enthusiastic about the re-launch of our website, PhRMA.org. With the goal of extending PhRMA’s online reach, the site is the central hub for our digital and social media communications efforts and represents a big step forward in our overall program.

PhRMA Statement on President’s 2014 Budget

 WASHINGTON, D.C. (April 10, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:

“President Obama has pressed for innovation and biomedical research, job creation, and controlling health care costs and yet his 2014 budget includes stale, previously rejected proposals that would undercut all of these efforts.  Notably, not one of these policies was included in the budget blueprints already passed by the House and the Senate. 

When Social Media and Traditional Media Meet

Today is a big day at Lilly. Not only does our CEO, John Lechleiter, begin chairing the PhRMA annual meeting, but we’re also launching a new digital communications platform that will enhance our conversations with media who cover the biopharmaceutical industry.

PhRMA Statement on President’s 2014 Budget

Rx Open and Rx On the Run Offer Help for Millions Affected by Weather

04.09.13 | By

In Washington last week it was still winter.  Suddenly, with temperatures in the 80’s it is summer with a vengeance.  The caprice of weather (it is snowing in Denver today and was in the 70s over the weekend) should remind us all how we all may be vulnerable in a weather emergency – especially a hurricane, flood or other large storm. 

PhRMA’s Contributions to The Fight Against Chronic Diseases

04.09.13 | By

According to the Kaiser Family Foundation, health care expenditures in the United States approached $2.6 trillion in 2010, over ten times the $256 billion spent in 1980.

The expectation this year: Americans will spend $2.9 trillion on health care.  And federal, state and local government agencies are in overdrive to find the best ways to reduce costs and still maintain quality patient care.

Rallying for Medical Research and Progress

04.09.13 | By


Subscribe to RSS - Opinion